Associate Director, Analytical Development and Clinical QC

Alexion Pharmaceuticals, Inc.; New Haven (CT); On-site; USD 100,000 - 150,000; Full time

Job summary

Alexion Pharmaceuticals, Inc. in New Haven, Connecticut is seeking a leader for their Late Stage Analytical team. This role involves overseeing analytical method validation and development, authoring regulatory submissions, and collaborating across teams to ensure project success. Candidates should have an advanced degree and significant experience in biologics analytical development. Expect a dynamic workplace that balances in-office collaboration with individual flexibility.

Qualifications

• 8–12+ years of progressive experience in biologics analytical development.
• Validated expert knowledge in method development, qualification, and validation.
• Strong command of ICH guidelines and compliance expectations for biologics.

Responsibilities

• Lead analytical method validation and transfers across clinical development stages.
• Oversee QC testing and maintain the health of the analytic program.
• Author regulatory documents for submissions to health authorities.

Skills

Analytical expertise

Management of development projects

Technical proficiency with monoclonal antibodies

Expertise in chromatography

Strong written communication skills

Problem-solving abilities

Education

PhD or MSc in Biochemistry, Analytical Chemistry, or related field

Tools

Chromatography Data Systems

Statistical software (e.g., JMP)

Job description

This position will play a key leadership role in Alexion’s Late Stage Analytical team, which requires analytical expertise and proven success in management of development projects through the CMC lifecycle. This position will lead multiple projects in parallel and working closely with other PDCS teams, Regulatory, QA and external QC laboratories as a lead to designing the strategy of late-stage analytical activities including method transfer/validation, compendia method verification, and overall testing strategy throughout all phases of the product lifecycle. Moreover, this position will lead to authoring regulatory filing in relevant analytic sections with a focused understanding of country‑specific requirements.

You Will Be Responsible For

• Leading all aspects of analytical method validation, transfers, and compendia method verifications across all stages of clinical development and method life‑cycle stages
• Analytical lead for CMC programs, emphasizing late‑stage programs that may be internal or external with cross‑functional collaboration.
• Analytical end‑to‑end strategy for key late‑stage biologics programs including analytic control strategy, method lifecycle and QC testing supervision, problem resolution and inquiries, and key BLA/commercial analytic
• Supervision of analytic QC testing, problem‑solving, and data analysis conducted for the CMC program. This provides oversight of the analytic program’s health and helps identify potential analytic and program risks early.
• Leading independently regulatory authoring for both medical and market‑facing submissions for all markets, including responses to health authority queries and requests for information.

You Will Need To Have

• Advanced degree (PhD or MSc) in Biochemistry, Analytical Chemistry, Molecular Biology, Pharmaceutical Sciences, or related field with 8–12+ years of progressive experience in biologics analytical development across clinical and commercial stages
• Validated first‑hand expert knowledge and technical proficiency with monoclonal antibodies, bispecifics, fusion proteins.
• Technical expertise in chromatography (e.g., SEC, RP, IEX), capillary electrophoresis (CE‑SDS, cIEF), spectroscopy (UV/Vis, fluorescence, CD), bioassays (binding, potency), and residuals/impurities testing (HCP, DNA, residual Protein A)
• Compendia method experience emphasizing USP, EP and JP compliance
• Strong written and verbal skills for clear reports, regulatory submissions, and presentations to technical and non‑technical collaborators
• Demonstrated success in method development, qualification/validation (per ICH Q2), transfer to QC/CMOs, and continued verification for commercial control strategies.
• Strong command of ICH (Q5E, Q6B, Q8–Q12), USP/EP, FDA/EMA expectations for biologics, GMP/GLP compliance, and authoring/reviewing CTD Module 3, IND/IMPD, BLA/MAA analytic sections and responses to agency queries.
• Proficiency with GxP compliant documentation, ALCOA+ data integrity principles, OOS/OOT handling, deviation/CAPA management, and audit readiness
• Ability to define critical quality attributes (CQAs), build specifications, and implement control approaches aligned with Quality by Build (QbB).

We Would Prefer You To Have

• Experience in microbiology assays (e.g., required day of harvest, bioburden, endotoxin, sterility, and CCIT)
• Background in analytic method development and sound scientific understanding of Critical Quality Attributes/QbD/DOE principles as well as statistical data analysis and relevant tools
• Experience leading all aspects of CDMO/CRO analytic activities including routine testing oversight, troubleshooting and investigations and method qualification, validation, and transfer.
• Experience in country specific compendia requirements and knowledge of CHP
• Experience leading ICH stability programs (Q1), shelf‑life modeling, and projections and related statistical approaches.
• Experience in extended characterization and comparability including forced degradation studies for process comparability.
• Familiarity with LIMS, ELN, Chromatography Data Systems, data visualization, and automation/robotics in analytic workflows
• Expertise with AI tools and statistical software, for example JMP
• Track record of building, mentoring, and developing high‑performing teams; resource planning, and performance management.

The duties of this role are generally conducted in a lab environment. As is typical of a lab‑based role, employees will work comfortably in a controlled environment with and around biological, infectious, and hazardous materials; gown/degown PPE; use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving and non‑linear thought, analysis, and dialogue; collaborate with others; maintain general availability during standard business hours.

When we put unexpected teams in the same room, we ignite ambitious thinking with the power to encourage life‑changing medicines! In‑person working gives us the platform we need to connect, work at pace and challenge perceptions. That’s why we work, on average, a minimum of four days per week from the office. But that doesn’t mean we’re not flexible. We balance the expectation of being in the office while respecting individual flexibility.

Why AstraZeneca

Here, courage, curiosity, and collaboration fuel a relentless focus on transforming cancer outcomes, powered by a pipeline that fuses cutting‑edge science with advanced technology. You will work in an environment where unexpected teams come together to spark bold ideas, backed by meaningful investment and a clear path from discovery to impact. We value kindness alongside ambition, and we empower leaders at every level to ask sharp questions, take smart risks, and turn data into decisions that help patients sooner.

Date Posted

01-May-2026

Closing Date

30-Jul-2026

Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.